Form 8-K - Current report:
SEC Accession No. 0001140361-23-052908
Filing Date
2023-11-13
Accepted
2023-11-13 16:19:49
Documents
18
Period of Report
2023-10-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20014138x1_8k.htm   iXBRL 8-K 63799
2 EXHIBIT 1.1 ny20014138x1_ex1-1.htm EX-1.1 238299
3 EXHIBIT 4.1 ny20014138x1_ex4-1.htm EX-4.1 457179
4 EXHIBIT 5.1 ny20014138x1_ex5-1.htm EX-5.1 18449
9 ny20014138x1_ex5-1img001.jpg GRAPHIC 3917
10 ny20014138x1_ex5-1img002.jpg GRAPHIC 2138
  Complete submission text file 0001140361-23-052908.txt   1094030

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmy-20231030.xsd EX-101.SCH 4696
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20231030_def.xml EX-101.DEF 18374
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20231030_lab.xml EX-101.LAB 28469
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20231030_pre.xml EX-101.PRE 20673
12 EXTRACTED XBRL INSTANCE DOCUMENT ny20014138x1_8k_htm.xml XML 8280
Mailing Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543
Business Address ROUTE 206 AND PROVINCE LINE ROAD PRINCETON NJ 08543 6092524621
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

EIN.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 231399071
SIC: 2834 Pharmaceutical Preparations